@Article{Szymańska2006,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="5",
number="2",
year="2006",
title="Endometrial hyperplasia: efficacy of treatment with vaginal tablet containing natural micronized progesterone",
abstract="  Objectives:    The aim of this study was to evaluate the efficiency of treatment with a vaginal tablet containing natural micronized progesterone in patients with endometrial hyperplasia.   Material and methods:    Forty one patients with endometrial hyperplasia were enrolled in this trial; 38 patients have been presented simple hyperplasia, 3 complex hyperplasia. All patients were treated with vaginal tablets containing micronized progesterone 2 x 100 mg/day for 3 months. During first month of treatment  6 patients were bleeding and were excluded from the study. 35 patients finished treatment.    Results:    We observed a total of 33 complete regressions (94%). Recurrence of simple hyperplasia occurred in 1 patient (3%), and in 1 patient (3%) we noticed progresion from simple to complex hyperplasia. 7 patients (17%) had irregular spotting, 4 (9,8%) had vaginal discomfort.    Conclusions:    Vaginal administration of natural micronized progesterone seems to be effective and safe therapy of benign endometrial hyperplasia, particularly indicated in women also affected by metabolic disorders.",
author="Szymańska, Beata
and Gardyszewska, Agnieszka
and Pabich, Joanna
and Czajkowski, Krzysztof",
pages="75--79",
url="https://www.termedia.pl/Endometrial-hyperplasia-efficacy-of-treatment-with-vaginal-tablet-containing-natural-micronized-progesterone,4,5939,1,1.html"
}